Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMGEN INCAMGN · Entity 2832 | SVP, Gen. Counsel & Secy. | April 25, 2015 | April 29, 2015 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMGEN INC
Report date April 25, 2015 · Filed April 29, 2015
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 95,018 |
Reported balance
After 2015-04-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2015-04-25 · Tax withholding · Disposed 1,898 · Balance 95,018 |
| Common StockSEC Table I · non-derivative | Direct | 93,949 |
Reported balance
After 2015-04-27 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2015-04-27 · Tax withholding · Disposed 1,069 · Balance 93,949 F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,088 RSUs which vest on 4/27/2016; 3,601 RSUs which vest in one installment of 1,773 on 1/28/2016 and one installment of 1,828 on 1/28/2017; 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018; and 2,627 RSUS which vest in three annual installments of 866, 867 and 894 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2: These shares include 363 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,088 RSUs which vest on 4/27/2016; 3,601 RSUs which vest in one installment of 1,773 on 1/28/2016 and one installment of 1,828 on 1/28/2017; 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018; and 2,627 RSUS which vest in three annual installments of 866, 867 and 894 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2: These shares include 363 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 27, 2015 Filed Apr 29, 2015 00:14 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,069 | $167.91 | $179,495.79 |
DisclosureSEC source: 0001127602-15-015486 · form4.xml · nonDerivative · entry 2 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,949 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,088 RSUs which vest on 4/27/2016; 3,601 RSUs which vest in one installment of 1,773 on 1/28/2016 and one installment of 1,828 on 1/28/2017; 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018; and 2,627 RSUS which vest in three annual installments of 866, 867 and 894 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 363 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 25, 2015 Filed Apr 29, 2015 00:14 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,898 | $167.91 | $318,693.18 |
DisclosureSEC source: 0001127602-15-015486 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,018 Read SEC document |
| March 27, 2015 Filed Mar 31, 2015 23:02 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 20,314 | $160.55 | $3,261,412.70 |
DisclosureSEC source: 0001127602-15-012986 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,916 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,808 RSUs which vest in one installment on 4/25/2015; 4,115 RSUs which vest in two annual installments of 2,027 and 2,088 on 4/27/2015 and 4/27/2016, respectively; 3,601 RSUs which vest in one installment of 1,773 on 1/28/2016 and one installment of 1,828 on 1/28/2017; 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018; and 2,627 RSUS which vest in three annual installments of 866, 867 and 894 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 477 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 04, 2015 Filed Mar 7, 2015 02:12 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 38,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-010549 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,962 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,808 RSUs which vest in one installment on 4/25/2015; 4,115 RSUs which vest in two annual installments of 2,027 and 2,088 on 4/27/2015 and 4/27/2016, respectively; 3,601 RSUs which vest in one installment of 1,773 on 1/28/2016 and one installment of 1,828 on 1/28/2017; 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018; and 2,627 RSUS which vest in three annual installments of 866, 867 and 894 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 406 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 30, 2015 Filed Feb 4, 2015 00:14 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 2,627 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-15-004146 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,230 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/30/2017, 1/30/2018 and 1/30/2019, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 3,808 RSUs which vest in one installment on 4/25/2015; 4,115 RSUs which vest in two annual installments of 2,027 and 2,088 on 4/27/2015 and 4/27/2016, respectively; 3,601 RSUs which vest in one installment of 1,773 on 1/28/2016 and one installment of 1,828 on 1/28/2017; 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018; and 2,627 RSUS which vest in three annual installments of 866, 867 and 894 on 1/30/2017, 1/30/2018 and 1/30/2019, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 406 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2015 Filed Jan 30, 2015 22:08 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 24 | $158.89 | $3,813.36 |
DisclosureSEC source: 0001127602-15-003498 · form4.xml · nonDerivative · entry 2 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,583 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,808 RSUs which vest in one installment on 4/25/2015; 4,115 RSUs which vest in two annual installments of 2,027 and 2,088 on 4/27/2015 and 4/27/2016, respectively; 3,601 RSUs which vest in one installment of 1,773 on 1/28/2016 and one installment of 1,828 on 1/28/2017; and 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 406 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2015 Filed Jan 30, 2015 22:08 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 625 | $158.89 | $99,306.25 |
DisclosureSEC source: 0001127602-15-003498 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,607 Read SEC document |
| December 31, 2014 Filed Jan 5, 2015 21:41 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 11,522 | $160.63 | $1,850,778.86 |
DisclosureSEC source: 0001127602-15-000710 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,252 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,808 RSUs which vest in one installment on 4/25/2015; 4,115 RSUs which vest in two annual installments of 2,027 and 2,088 on 4/27/2015 and 4/27/2016, respectively; 5,374 RSUs which vest in two equal installments of 1,773 each on 1/28/2015 and 1/28/2016 and one installment of 1,828 on 1/28/2017; and 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 471 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| November 04, 2014 Filed Nov 5, 2014 21:38 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-031293 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,726 F1 · kind: This transaction involved a gift of securities by the reporting person to Cornell University Law School to fund an endowed scholarship. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 22,081 RSUs which fully vest on 12/31/2014; 3,808 RSUs which vest in one installment on 4/25/2015; 4,115 RSUs which vest in two annual installments of 2,027 and 2,088 on 4/27/2015 and 4/27/2016, respectively; 5,374 RSUs which vest in two equal installments of 1,773 each on 1/28/2015 and 1/28/2016 and one installment of 1,828 on 1/28/2017; and 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 423 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 27, 2014 Filed Apr 29, 2014 22:03 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 38 | $111.41 | $4,233.58 |
DisclosureSEC source: 0001127602-14-015514 · form4.xml · nonDerivative · entry 4 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,600 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 22,081 RSUs which fully vest on 12/31/2014; 3,808 RSUs which vest in one installment on 4/25/2015; 4,115 RSUs which vest in two annual installments of 2,027 and 2,088 on 4/27/2015 and 4/27/2016, respectively; 5,374 RSUs which vest in two equal installments of 1,773 each on 1/28/2015 and 1/28/2016 and one installment of 1,828 on 1/28/2017; and 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 297 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 27, 2014 Filed Apr 29, 2014 22:03 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,010 | $111.41 | $112,524.10 |
DisclosureSEC source: 0001127602-14-015514 · form4.xml · nonDerivative · entry 3 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,638 Read SEC document |
| April 26, 2014 Filed Apr 29, 2014 22:03 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 723 | $111.41 | $80,549.43 |
DisclosureSEC source: 0001127602-14-015514 · form4.xml · nonDerivative · entry 2 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,648 Read SEC document |
| April 25, 2014 Filed Apr 29, 2014 22:03 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,842 | $113.72 | $209,472.24 |
DisclosureSEC source: 0001127602-14-015514 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,371 Read SEC document |
| March 14, 2014 Filed Mar 18, 2014 20:38 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 14,278 | $123.96 | $1,769,900.88 |
DisclosureSEC source: 0001127602-14-012052 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,213 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,450 RSUs which fully vest on 4/26/2014; 22,081 RSUs which fully vest on 12/31/2014; 7,504 RSUs which vest in one installment of 3,696 on 4/25/2014 and one installment of 3,808 on 4/25/2015; 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 5,374 RSUs which vest in two equal installments of 1,773 each on 1/28/2015 and 1/28/2016 and one installment of 1,828 on 1/28/2017; and 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 372 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 05, 2014 Filed Mar 7, 2014 22:41 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 27,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-010761 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,415 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,450 RSUs which fully vest on 4/26/2014; 22,081 RSUs which fully vest on 12/31/2014; 7,504 RSUs which vest in one installment of 3,696 on 4/25/2014 and one installment of 3,808 on 4/25/2015; 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 5,374 RSUs which vest in two equal installments of 1,773 each on 1/28/2015 and 1/28/2016 and one installment of 1,828 on 1/28/2017; and 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 296 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 31, 2014 Filed Feb 4, 2014 23:08 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 3,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-14-004399 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,053 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/31/2016, 1/31/2017 and 1/31/2018, respectively. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 1,450 RSUs which fully vest on 4/26/2014; 22,081 RSUs which fully vest on 12/31/2014; 7,504 RSUs which vest in one installment of 3,696 on 4/25/2014 and one installment of 3,808 on 4/25/2015; 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 5,374 RSUs which vest in two equal installments of 1,773 each on 1/28/2015 and 1/28/2016 and one installment of 1,828 on 1/28/2017; and 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 296 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 28, 2013 Filed Apr 30, 2013 21:25 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 744 | $108.38 | $80,634.72 |
DisclosureSEC source: 0001127602-13-014783 · form4.xml · nonDerivative · entry 2 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,537 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,450 RSUs which fully vest on 4/26/2014; 22,081 RSUs which fully vest on 12/31/2014; 7,504 RSUs which vest in one installment of 3,696 on 4/25/2014 and one installment of 3,808 on 4/25/2015; 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 5,374 RSUs which vest in two equal installments of 1,773 each on 1/28/2015 and 1/28/2016 and one installment of 1,828 on 1/28/2017. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 142 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| April 26, 2013 Filed Apr 30, 2013 21:25 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 757 | $108.66 | $82,255.62 |
DisclosureSEC source: 0001127602-13-014783 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,281 Read SEC document |
| April 25, 2013 Filed Apr 26, 2013 21:51 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,929 | $104.93 | $202,409.97 |
DisclosureSEC source: 0001127602-13-014617 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,038 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; 7,504 RSUs which vest in one installment of 3,696 on 4/25/2014 and one installment of 3,808 on 4/25/2015; 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 5,374 RSUs which vest in two equal installments of 1,773 each on 1/28/2015 and 1/28/2016 and one installment of 1,828 on 1/28/2017. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 142 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 15, 2013 Filed Mar 19, 2013 23:58 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 8,647 | $92.18 | $797,080.46 |
DisclosureSEC source: 0001127602-13-011480 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,967 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015; 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 5,374 RSUs which vest in two equal installments of 1,773 each on 1/28/2015 and 1/28/2016 and one installment of 1,828 on 1/28/2017. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 142 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| March 06, 2013 Filed Mar 8, 2013 23:33 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 16,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-010167 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,555 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015; 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 5,374 RSUs which vest in two equal installments of 1,773 each on 1/28/2015 and 1/28/2016 and one installment of 1,828 on 1/28/2017. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include 83 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| January 28, 2013 Filed Jan 31, 2013 01:04 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 5,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-13-003252 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,984 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/28/2015, 1/28/2016 and 1/28/2017, respectively. F2 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015; 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; and 5,374 RSUs which vest in two equal installments of 1,773 each on 1/28/2015 and 1/28/2016 and one installment of 1,828 on 1/28/2017. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F3 · balance_after: These shares include 83 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $58.43 | $0.00 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · derivative · entry 16 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2020-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $50.44 | $0.00 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · derivative · entry 15 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 30,000 shares Expires 2016-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $42.13 | $0.00 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · derivative · entry 14 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2015-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 42,109 | $0.00 Strike: $71.88 | $0.00 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · derivative · entry 13 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,109 shares Expires 2013-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionIso (Right to Buy) · Derivative | 1,391 | $0.00 Strike: $71.88 | $0.00 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · derivative · entry 12 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,391 shares Expires 2013-04-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 20,000 | $83.93 | $1,678,540.00 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · nonDerivative · entry 11 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,558 F5 · price: The price reported is an average price. The prices ranged from $83.90 to $83.97 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. F6 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015; and 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F7 · balance_after: These shares include 31 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 30,000 | $83.95 | $2,518,620.00 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · nonDerivative · entry 10 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,558 F4 · price: The price reported is an average price. The prices ranged from $83.90 to $84.03 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 20,000 | $84.23 | $1,684,660.00 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · nonDerivative · entry 9 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,558 F3 · price: The price reported is an average price. The prices ranged from $84.22 to $84.26 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 42,109 | $84.25 | $3,547,514.81 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · nonDerivative · entry 8 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,558 F2 · price: The price reported is an average price. The prices ranged from $84.23 to $84.28 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 1,391 | $84.29 | $117,243.22 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · nonDerivative · entry 7 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,667 F1 · price: The price reported is an average price. The prices ranged from $84.28 to $84.29 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 20,000 | $58.43 | $1,168,600.00 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · nonDerivative · entry 6 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 30,000 | $50.44 | $1,513,200.00 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · nonDerivative · entry 5 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 20,000 | $42.13 | $842,600.00 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · nonDerivative · entry 4 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 42,109 | $71.88 | $3,026,794.92 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · nonDerivative · entry 3 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionCommon Stock | 1,391 | $71.88 | $99,985.08 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · nonDerivative · entry 2 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 27, 2012 Filed Aug 1, 2012 00:00 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 30,000 | $82.00 | $2,460,000.00 |
DisclosureSEC source: 0001127602-12-023284 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,558 Read SEC document |
| April 29, 2012 Filed May 2, 2012 01:11 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 1,331 | $71.64 | $95,352.84 |
DisclosureSEC source: 0001127602-12-015265 · form4.xml · nonDerivative · entry 3 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,527 F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 1,425 RSUs which fully vest on 4/28/2013; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015; and 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| April 28, 2012 Filed May 2, 2012 01:11 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 666 | $71.64 | $47,712.24 |
DisclosureSEC source: 0001127602-12-015265 · form4.xml · nonDerivative · entry 2 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,858 Read SEC document |
| April 27, 2012 Filed May 2, 2012 01:11 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 6,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-015265 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,524 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Read SEC document |
| April 26, 2012 Filed Apr 30, 2012 21:18 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 677 | $70.19 | $47,518.63 |
DisclosureSEC source: 0001127602-12-014960 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,383 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 2,900 RSUs which vest in two equal annual installments of 1,450 each commencing 4/26/2013; 22,081 RSUs which fully vest on 12/31/2014; and 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 16, 2012 Filed Mar 20, 2012 22:00 UTC | AMGEN INC AMGN · Entity 2832 | Tax withholdingCommon Stock | 2,443 | $68.26 | $166,759.18 |
DisclosureSEC source: 0001127602-12-011454 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,060 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; 22,081 RSUs which fully vest on 12/31/2014; and 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| March 14, 2012 Filed Mar 16, 2012 00:02 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 5,232 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-010821 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,503 F1 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; 22,081 RSUs which fully vest on 12/31/2014; and 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| January 31, 2012 Filed Feb 3, 2012 01:15 UTC | AMGEN INC AMGN · Entity 2832 | GrantCommon Stock | 22,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-003813 · form4.xml · nonDerivative · entry 1 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,271 F1 · shares: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in full on December 31, 2014. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. F2 · balance_after: These shares include the following RSUs granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; 22,081 RSUs which fully vest on 12/31/2014; and 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 02:08 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $42.13 | $0.00 |
DisclosureSEC source: 0001127602-12-003257 · form4.xml · derivative · entry 12 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2015-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 02:08 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 41,902 | $0.00 Strike: $62.55 | $0.00 |
DisclosureSEC source: 0001127602-12-003257 · form4.xml · derivative · entry 11 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,902 shares Expires 2014-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 02:08 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionIso (Right to Buy) · Derivative | 1,598 | $0.00 Strike: $62.55 | $0.00 |
DisclosureSEC source: 0001127602-12-003257 · form4.xml · derivative · entry 10 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,598 shares Expires 2014-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 02:08 UTC | AMGEN INC AMGN · Entity 2832 | Exercise / conversionNqso (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $58.61 | $0.00 |
DisclosureSEC source: 0001127602-12-003257 · form4.xml · derivative · entry 9 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2012-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2012 Filed Feb 1, 2012 02:08 UTC | AMGEN INC AMGN · Entity 2832 | SaleCommon Stock | 20,000 | $68.68 | $1,373,600.00 |
DisclosureSEC source: 0001127602-12-003257 · form4.xml · nonDerivative · entry 8 SCOTT DAVID J · CIK 0001145154 · SVP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,190 F4 · balance_after: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 2,850 RSUs which fully vest on 4/29/2012; 2,850 RSUs which vest in two equal annual installments of 1,425 each commencing 4/28/2012; 4,350 RSUs which vest in three equal annual installments of 1,450 each commencing 4/26/2012; and 11,200 RSUs which vest in two equal installments of 3,696 each on 4/25/2013 and 4/25/2014 and one installment of 3,808 on 4/25/2015. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.